The CARI program and overcoming commercialization challenges in the Canadian isotope sector

CARI is a collaboration between The Centre for Probe Development and Commercialization (CPDC) and adMare BioInnovations (adMare) working to bring respective resources together to advance an area of tremendous therapeutic and commercial potential in which Canada can gain considerable global competitive advantage in radiopharmaceuticals.

Join us for this event where we will learn how the CARI program is exploring opportunities arising from academic discoveries and early enterprises, establishing rigorous drug development programs around selected opportunities, and driving the generation of proof-of-principle for the commercialization of new radiopharmaceutical assets.